Cargando…
In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan
Unveiling the mechanism of action of a drug is key to understand the benefits and adverse reactions of a medication in an organism. However, in complex diseases such as heart diseases there is not a unique mechanism of action but a wide range of different responses depending on the patient. Explorin...
Autores principales: | Jorba, Guillem, Aguirre-Plans, Joaquim, Junet, Valentin, Segú-Vergés, Cristina, Ruiz, José Luis, Pujol, Albert, Fernández-Fuentes, Narcís, Mas, José Manuel, Oliva, Baldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018085/ https://www.ncbi.nlm.nih.gov/pubmed/32053711 http://dx.doi.org/10.1371/journal.pone.0228926 |
Ejemplares similares
-
Prediction of Adverse Drug Reaction Linked to Protein Targets Using Network-Based Information and Machine Learning
por: Galletti, Cristiano, et al.
Publicado: (2022) -
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
por: Carcereny, Enric, et al.
Publicado: (2021) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2021) -
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
por: Coto-Segura, Pablo, et al.
Publicado: (2023)